AtriCure, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from AtriCure, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.9×Over the last 3 years its own operating cash paid for 92% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 68% of Healthcare companies in United States.
Cash Locked Ratio
$22For every $100 of sales, $22 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $21 tied up three years earlier.
Less money tied up than 53% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$17Sales grew 62% in 3 years; of every extra $100 of sales, $17 became extra profit.
Lower than 52% of Healthcare companies in United States.
Asset Productivity Ratio
+62% / +12%In 3 years sales changed by +62% while total assets changed by +12%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+3%Cash, after subtracting all debt, equals 3% of its market value (net cash).
Lower than 62% of Healthcare companies in United States.
Tangible Assets Ratio
57%Of every $100 the company owns, $57 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 72% of Healthcare companies in United States.
Tangible Net Worth Ratio
43%Of every $100 of net worth, $43 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 57% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
AtriCure, Inc. owes $0.24 for every $1 it owns. AtriCure, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
282.4Investors pay $282.4 for every $1 of AtriCure, Inc.'s yearly profit, higher than 98% of Healthcare companies in United States.
P/B ratio
5.84The share price is 5.84 times AtriCure, Inc.'s book value per share, higher than 76% of Healthcare companies in United States.
Market cap
$3.0 BThe total market value of all of AtriCure, Inc.'s shares at today's price (share price × number of shares), larger than 80% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$516 MWhat AtriCure, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$10.15Net worth divided by the number of shares. The share price of $59.30 is 5.8 times this, which is the P/B above.
Return on equity (ROE)
2.1%AtriCure, Inc. earned 2.1% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.
Owes vs Owns
0.24×AtriCure, Inc. owes $0.24 for every $1 it owns (low), lower than 68% of Healthcare companies in United States.
Dividend yield
NoneAtriCure, Inc. does not currently pay a dividend.
Revenue growth
+15%Revenue rose 15% in the year to Dec 2025, and grew 17% a year on average over 3 years.
Profit growth
LossAtriCure, Inc. made a loss in each of the last two years.
Profit margin
-2.1%AtriCure, Inc. lost $2 for every $100 of revenue.
Interest cover
Not coveredAtriCure, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashAtriCure, Inc. held $94 M more cash than debt (net cash) at Dec 2025.
Questions
What is AtriCure, Inc.'s P/E ratio?
Investors pay $282.4 for every $1 of AtriCure, Inc.'s yearly profit, higher than 98% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For AtriCure, Inc.: $3.0 B ÷ $516 M (30 Jun 2026) = 5.8.
What is AtriCure, Inc.'s return on equity?
AtriCure, Inc. earned 2.1% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.
How much does AtriCure, Inc. owe compared with what it owns?
AtriCure, Inc. owes $0.24 for every $1 it owns (low), lower than 68% of Healthcare companies in United States.
Does AtriCure, Inc. pay a dividend?
No. AtriCure, Inc. does not currently pay a dividend.
Is AtriCure, Inc.'s revenue growing?
Revenue rose 15% in the year to Dec 2025, and grew 17% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.